CA2926049C - Metabolically optimized cell culture - Google Patents
Metabolically optimized cell culture Download PDFInfo
- Publication number
- CA2926049C CA2926049C CA2926049A CA2926049A CA2926049C CA 2926049 C CA2926049 C CA 2926049C CA 2926049 A CA2926049 A CA 2926049A CA 2926049 A CA2926049 A CA 2926049A CA 2926049 C CA2926049 C CA 2926049C
- Authority
- CA
- Canada
- Prior art keywords
- cell culture
- cells
- cell
- lactate
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361889815P | 2013-10-11 | 2013-10-11 | |
| US61/889,815 | 2013-10-11 | ||
| PCT/US2014/059993 WO2015054554A1 (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2926049A1 CA2926049A1 (en) | 2015-04-16 |
| CA2926049C true CA2926049C (en) | 2023-09-05 |
Family
ID=52813657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2926049A Active CA2926049C (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20160244725A1 (https=) |
| EP (3) | EP3351620B1 (https=) |
| JP (3) | JP6663854B2 (https=) |
| KR (4) | KR102610425B1 (https=) |
| CN (2) | CN114717196A (https=) |
| AU (2) | AU2014331776B2 (https=) |
| CA (1) | CA2926049C (https=) |
| DK (3) | DK3351620T3 (https=) |
| EA (2) | EA201991976A1 (https=) |
| ES (2) | ES2678945T3 (https=) |
| HU (2) | HUE039551T2 (https=) |
| IL (2) | IL244511A0 (https=) |
| MX (2) | MX384960B (https=) |
| PL (2) | PL3055409T3 (https=) |
| SG (2) | SG10201800772TA (https=) |
| WO (1) | WO2015054554A1 (https=) |
| ZA (1) | ZA201601550B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| US20160244726A1 (en) * | 2013-10-11 | 2016-08-25 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| US20160244725A1 (en) | 2013-10-11 | 2016-08-25 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| JP7260018B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260020B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260011B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260009B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260021B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7310945B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7310947B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7260013B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260012B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7272480B2 (ja) * | 2017-04-27 | 2023-05-12 | 株式会社三洋物産 | 遊技機 |
| JP7310952B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| WO2019071076A1 (en) | 2017-10-06 | 2019-04-11 | Lonza Ltd. | AUTOMATED CONTROL OF CELL CULTURE BY SPECTROSCOPY RAMAN |
| IL315801A (en) | 2017-10-16 | 2024-11-01 | Regeneron Pharma | Perfusion bioreactor and methods of using it |
| EP3717656B1 (en) * | 2017-11-30 | 2024-03-13 | F. Hoffmann-La Roche AG | Process for culturing mammalian cells |
| HRP20260157T1 (hr) * | 2018-03-29 | 2026-03-27 | F. Hoffmann - La Roche Ag | Moduliranje laktogene aktivnosti u stanicama sisavaca |
| GB201810772D0 (en) * | 2018-06-29 | 2018-08-15 | Ge Healthcare Bio Sciences Ab | Method in bioprocess purification system |
| JP7231355B2 (ja) * | 2018-08-22 | 2023-03-01 | 日機装株式会社 | 細胞培養方法および細胞培養装置 |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| EP3870604B1 (en) | 2018-10-26 | 2022-11-23 | F. Hoffmann-La Roche AG | Multispecific antibody screening method using recombinase mediated cassette exchange |
| JP2020151559A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| JP2020151560A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| EP3985097A1 (en) * | 2020-10-14 | 2022-04-20 | Sartorius Stedim Biotech GmbH | A method and system for configuring and/or setup of a downstream process for processing a biomass |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US6165741A (en) | 1997-05-30 | 2000-12-26 | The Trustees Of The University Of Pennsylvania | Method for rapid detection of bacterial growth in cultures |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| WO2002057423A2 (en) | 2001-01-16 | 2002-07-25 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| US6953692B2 (en) * | 2001-12-18 | 2005-10-11 | Bayer Pharmaceuticals Corporation | Device and method for seed-train expansion of mammalian cells |
| US7039770B1 (en) | 2002-03-05 | 2006-05-02 | Juniper Networks, Inc. | Low latency request dispatcher |
| CA2417689C (en) | 2002-03-05 | 2006-05-09 | F. Hoffmann-La Roche Ag | Improved methods for growing mammalian cells in vitro |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| ATE472597T2 (de) | 2003-05-15 | 2010-07-15 | Wyeth Llc | Kontrollierte glukosezufuhr für tierzellkultur |
| US7531327B2 (en) * | 2004-07-23 | 2009-05-12 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
| TWI374935B (en) | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| TWI364458B (en) * | 2004-08-27 | 2012-05-21 | Wyeth Res Ireland Ltd | Production of tnfr-lg |
| BRPI0618178A2 (pt) * | 2005-11-02 | 2011-08-23 | Wyeth Corp | métodos para adaptação de células de mamìferos |
| US10155816B2 (en) | 2005-11-28 | 2018-12-18 | Genmab A/S | Recombinant monovalent antibodies and methods for production thereof |
| US7575890B2 (en) | 2006-01-18 | 2009-08-18 | Oxygen Enterprises, Ltd. | Method for rapid detection and evaluation of cultured cell growth |
| EP2064315B1 (en) | 2006-11-03 | 2015-05-13 | Wyeth LLC | Glycolysis-inhibiting substances in cell culture |
| WO2008151219A1 (en) | 2007-06-04 | 2008-12-11 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| WO2009023562A2 (en) | 2007-08-09 | 2009-02-19 | Wyeth | Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| UA106047C2 (uk) * | 2008-06-13 | 2014-07-25 | Сентокор Орто Байотек Інк. | Спосіб отримання високої щільності життєздатних клітин в культурі клітин ссавців |
| US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| US9428727B2 (en) * | 2010-04-26 | 2016-08-30 | Novartis Ag | Cell culture medium |
| PL2576580T3 (pl) * | 2010-05-28 | 2017-03-31 | F.Hoffmann-La Roche Ag | Zmniejszenie poziomu mleczanu i zwiększenie wytwarzania polipeptydu przez obniżenie poziomu ekspresji dehydrogenazy mleczanowej i kinazy dehydrogenazy pirogronianowej |
| TWI637057B (zh) | 2012-11-09 | 2018-10-01 | 拜爾沙納有限公司 | 具交替生物反應器用途之不連續進料批次製程 |
| US20150353542A1 (en) * | 2013-01-14 | 2015-12-10 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| US20160244725A1 (en) | 2013-10-11 | 2016-08-25 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
-
2014
- 2014-10-10 US US15/028,521 patent/US20160244725A1/en not_active Abandoned
- 2014-10-10 SG SG10201800772TA patent/SG10201800772TA/en unknown
- 2014-10-10 DK DK18161278.9T patent/DK3351620T3/da active
- 2014-10-10 EP EP18161278.9A patent/EP3351620B1/en not_active Revoked
- 2014-10-10 ES ES14851841.8T patent/ES2678945T3/es active Active
- 2014-10-10 KR KR1020237008467A patent/KR102610425B1/ko active Active
- 2014-10-10 HU HUE14851841A patent/HUE039551T2/hu unknown
- 2014-10-10 MX MX2020011334A patent/MX384960B/es unknown
- 2014-10-10 MX MX2016004564A patent/MX376623B/es active IP Right Grant
- 2014-10-10 SG SG11201601681QA patent/SG11201601681QA/en unknown
- 2014-10-10 JP JP2016547976A patent/JP6663854B2/ja active Active
- 2014-10-10 KR KR1020227003381A patent/KR102510238B1/ko active Active
- 2014-10-10 CA CA2926049A patent/CA2926049C/en active Active
- 2014-10-10 CN CN202210497778.2A patent/CN114717196A/zh active Pending
- 2014-10-10 CN CN201480055499.4A patent/CN105637085A/zh active Pending
- 2014-10-10 PL PL14851841T patent/PL3055409T3/pl unknown
- 2014-10-10 PL PL18161278T patent/PL3351620T3/pl unknown
- 2014-10-10 DK DK14851841.8T patent/DK3055409T3/en active
- 2014-10-10 EP EP20193898.2A patent/EP3812453B1/en active Active
- 2014-10-10 ES ES18161278T patent/ES2833471T3/es active Active
- 2014-10-10 HU HUE18161278A patent/HUE051049T2/hu unknown
- 2014-10-10 EP EP14851841.8A patent/EP3055409B1/en not_active Revoked
- 2014-10-10 KR KR1020217011547A patent/KR102358807B1/ko active Active
- 2014-10-10 EA EA201991976A patent/EA201991976A1/ru unknown
- 2014-10-10 KR KR1020167009163A patent/KR102243980B1/ko active Active
- 2014-10-10 AU AU2014331776A patent/AU2014331776B2/en active Active
- 2014-10-10 WO PCT/US2014/059993 patent/WO2015054554A1/en not_active Ceased
- 2014-10-10 DK DK20193898.2T patent/DK3812453T3/da active
- 2014-10-10 EA EA201690600A patent/EA033783B1/ru active IP Right Revival
-
2016
- 2016-03-04 ZA ZA2016/01550A patent/ZA201601550B/en unknown
- 2016-03-08 IL IL244511A patent/IL244511A0/en unknown
-
2018
- 2018-11-06 IL IL262833A patent/IL262833A/en unknown
-
2020
- 2020-02-17 JP JP2020024484A patent/JP6967620B2/ja active Active
- 2020-08-04 US US16/984,531 patent/US20210087535A1/en active Pending
-
2021
- 2021-01-14 AU AU2021200193A patent/AU2021200193B2/en active Active
- 2021-10-25 JP JP2021173755A patent/JP7377243B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021200193B2 (en) | Metabolically optimized cell culture | |
| US12545717B2 (en) | Metabolically optimized cell culture | |
| US20160244726A1 (en) | Metabolically optimized cell culture | |
| HK40042432A (en) | Metabolically optimized cell culture | |
| HK1253275B (en) | Metabolically optimized cell culture | |
| HK1223122B (en) | Metabolically optimized cell culture | |
| BR122024020669A2 (pt) | Método para cultivar células, e, célula hospedeira metabolicamente alterada | |
| BR122024020665A2 (pt) | Método para cultivar células, e, célula hospedeira metabolicamente alterada | |
| BR112016007739B1 (pt) | Método para cultivar células | |
| EA045030B1 (ru) | Метаболически оптимизированная клеточная культура | |
| EA040764B1 (ru) | Метаболически оптимизированная клеточная культура |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20191001 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD Year of fee payment: 10 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240923 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240923 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240923 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD Year of fee payment: 11 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250924 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250924 |